BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15993614)

  • 1. Design, synthesis, and biological characterization of potential antiatherogenic nitric oxide releasing tocopherol analogs.
    López GV; Batthyány C; Blanco F; Botti H; Trostchansky A; Migliaro E; Radi R; González M; Cerecetto H; Rubbo H
    Bioorg Med Chem; 2005 Oct; 13(20):5787-96. PubMed ID: 15993614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second generation of alpha-tocopherol analogs-nitric oxide donors: Synthesis, physicochemical, and biological characterization.
    López GV; Blanco F; Hernández P; Ferreira A; Piro OE; Batthyány C; González M; Rubbo H; Cerecetto H
    Bioorg Med Chem; 2007 Sep; 15(18):6262-72. PubMed ID: 17627828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NO-donor phenols: a new class of products endowed with antioxidant and vasodilator properties.
    Boschi D; Tron GC; Lazzarato L; Chegaev K; Cena C; Di Stilo A; Giorgis M; Bertinaria M; Fruttero R; Gasco A
    J Med Chem; 2006 May; 49(10):2886-97. PubMed ID: 16686532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans.
    Buonsanti MF; Bertinaria M; Stilo AD; Cena C; Fruttero R; Gasco A
    J Med Chem; 2007 Oct; 50(20):5003-11. PubMed ID: 17845020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NO-donor melatonin derivatives: synthesis and in vitro pharmacological characterization.
    Chegaev K; Lazzarato L; Rolando B; Marini E; Tosco P; Cena C; Fruttero R; Bertolini F; Reist M; Carrupt PA; Lucini V; Fraschini F; Gasco A
    J Pineal Res; 2007 Apr; 42(4):371-85. PubMed ID: 17439554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel antioxidant agents deriving from molecular combination of Vitamin C and NO-donor moieties.
    Cena C; Chegaev K; Balbo S; Lazzarato L; Rolando B; Giorgis M; Marini E; Fruttero R; Gasco A
    Bioorg Med Chem; 2008 May; 16(9):5199-206. PubMed ID: 18359636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphiphilic NO-donor antioxidants.
    Chegaev K; Lazzarato L; Rolando B; Marini E; Lopez GV; Bertinaria M; Di Stilo A; Fruttero R; Gasco A
    ChemMedChem; 2007 Feb; 2(2):234-40. PubMed ID: 17183594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Edaravone derivatives containing NO-donor functions.
    Chegaev K; Cena C; Giorgis M; Rolando B; Tosco P; Bertinaria M; Fruttero R; Carrupt PA; Gasco A
    J Med Chem; 2009 Jan; 52(2):574-8. PubMed ID: 19113954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties.
    Chegaev K; Lazzarato L; Tosco P; Cena C; Marini E; Rolando B; Carrupt PA; Fruttero R; Gasco A
    J Med Chem; 2007 Apr; 50(7):1449-57. PubMed ID: 17335184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel analgesic/anti-inflammatory agents: diarylpyrrole acetic esters endowed with nitric oxide releasing properties.
    Biava M; Porretta GC; Poce G; Battilocchio C; Alfonso S; Rovini M; Valenti S; Giorgi G; Calderone V; Martelli A; Testai L; Sautebin L; Rossi A; Papa G; Ghelardini C; Di Cesare Mannelli L; Giordani A; Anzellotti P; Bruno A; Patrignani P; Anzini M
    J Med Chem; 2011 Nov; 54(22):7759-71. PubMed ID: 21992176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The furoxan system: design of selective nitric oxide (NO) donor inhibitors of COX-2 endowed with anti-aggregatory and vasodilating activities.
    Del Grosso E; Boschi D; Lazzarato L; Cena C; Di Stilo A; Fruttero R; Moro S; Gasco A
    Chem Biodivers; 2005 Jul; 2(7):886-900. PubMed ID: 17193179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New donors and acceptors of nitrogen oxide as a potential therapeutical agents].
    Elinova VI; Bobko AA; Mazhukin DG; Markel' AL; Khramtsov VV
    Bioorg Khim; 2003; 29(4):434-41. PubMed ID: 12947767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants.
    Cena C; Boschi D; Tron GC; Chegaev K; Lazzarato L; Di Stilo A; Aragno M; Fruttero R; Gasco A
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5971-4. PubMed ID: 15546710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrosyl-cobinamide, a new and direct nitric oxide releasing drug effective in vivo.
    Broderick KE; Alvarez L; Balasubramanian M; Belke DD; Makino A; Chan A; Woods VL; Dillmann WH; Sharma VS; Pilz RB; Bigby TD; Boss GR
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1432-40. PubMed ID: 18040067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction studies between human alpha-tocopherol transfer protein and nitric oxide donor tocopherol analogues with LDL-protective activity.
    López GV; Gómez LE; Campillo N; Páez JA; Giles K; Atkinson J; González M; Rubbo H; Cerecetto H
    Bioorg Med Chem; 2009 Dec; 17(24):8143-8. PubMed ID: 19897374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nitric oxide donor antioxidants containing the phenol vitamin E substructure and a furoxan moiety on ischemia/reperfusion injury.
    Di Stilo A; Chegaev K; Lazzarato L; Fruttero R; Gasco A; Rastaldo R; Cappello S
    Arzneimittelforschung; 2009; 59(3):111-6. PubMed ID: 19402340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of furoxancarbonitriles as a new class of vasodilators.
    Gasco AM; Boschi D; Di Stilo A; Medana C; Gasco A; Martorana PA; Schönafinger K
    Arzneimittelforschung; 1998 Mar; 48(3):212-8. PubMed ID: 9553676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NO-glibenclamide derivatives: prototypes of a new class of nitric oxide-releasing anti-diabetic drugs.
    Calderone V; Rapposelli S; Martelli A; Digiacomo M; Testai L; Torri S; Marchetti P; Breschi MC; Balsamo A
    Bioorg Med Chem; 2009 Aug; 17(15):5426-32. PubMed ID: 19595600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins.
    Lazzarato L; Donnola M; Rolando B; Chegaev K; Marini E; Cena C; Di Stilo A; Fruttero R; Biondi S; Ongini E; Gasco A
    J Med Chem; 2009 Aug; 52(16):5058-68. PubMed ID: 20560642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis and vascular relaxing activity of arecoline derivatives coupled with nitric oxide donors].
    Huang ST; Huang WL; Zhang HB
    Yao Xue Xue Bao; 2006 Jan; 41(1):71-5. PubMed ID: 16683531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.